Gliclize - 40

Gliclize 40 – Gliclazide IP 40 Mg

Gliclazide IP 40 Mg

Exporter, Distributor Drop shipper to Russia, Brazil, Colombia, Latin America And East Asia

Gliclize 40 contains Gliclazide IP 40 mg, a sulfonylurea antidiabetic medication indicated for the management of Type 2 Diabetes Mellitus. It helps lower blood glucose levels by stimulating insulin secretion from the pancreas, supporting effective glycemic control alongside a healthy diet and regular exercise.

Contain

Gliclazide IP 40 Mg

Strength

40 Mg

Packaging

10X10TAB

Category

Categories:

Manufacturer

Johnlee Pharmaceuticals Pvt. Ltd

Brand

Gliclize

SEND US A MESSAGE

    CONTACT INFORMATION

    501, EAST BAY, BAYVUE, DR M B VELKAR MARG,
    KALBADEVI, MUMBAI-400002.

    +91 96531 13180

    sales@vinixbiopharma.com

    Do you have questions about how we can help your company? Send us an email and we’ll get in touch shortly.

    Product Overview

    Gliclize 40 contains Gliclazide, a second-generation sulfonylurea oral antidiabetic medication used for the effective management of Type 2 Diabetes Mellitus. It is prescribed to help improve blood glucose control in adults when diet, exercise, and lifestyle modifications alone are insufficient. Gliclazide has been widely used in diabetes management due to its proven efficacy in stimulating insulin secretion and maintaining stable glycemic control.

    Gliclize 40 is commonly recommended as monotherapy or in combination with other oral antidiabetic agents or insulin, depending on the patient’s clinical condition and treatment requirements. By supporting consistent blood glucose regulation, it helps reduce the risk of long-term diabetes-related complications and contributes to comprehensive diabetes management.

    Manufactured under stringent pharmaceutical quality standards, Gliclize 40 delivers consistent efficacy, safety, and reliability, making it a trusted therapeutic option in modern diabetic care.


    How It Works

    Gliclazide works by stimulating the beta cells of the pancreas to release insulin, helping lower blood glucose levels. It also improves the body’s response to naturally produced insulin, promoting better glucose utilization and supporting effective glycemic control in patients with Type 2 Diabetes Mellitus.


    Therapeutic Applications

    Gliclize 40 may be prescribed for the management of:

    • Type 2 Diabetes Mellitus
    • Blood Glucose Control
    • Combination Therapy with other Antidiabetic Medications
    • Long-Term Glycemic Management
    • Patients inadequately controlled by diet and exercise alone

    Key Benefits

    • Helps effectively lower blood glucose levels.
    • Stimulates natural insulin secretion from the pancreas.
    • Supports long-term glycemic control.
    • Can be used alone or in combination with other antidiabetic therapies.
    • Convenient oral tablet for daily diabetes management.
    • Manufactured under stringent pharmaceutical quality standards.

    Quality Commitment

    Vinix Biopharma is committed to delivering high-quality antidiabetic medicines manufactured in accordance with stringent pharmaceutical quality standards. Gliclize 40 undergoes comprehensive quality assurance and rigorous testing to ensure safety, efficacy, consistency, and reliability. Every batch is carefully evaluated to maintain product integrity and support optimal patient care.


    Storage Information

    Store in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.


    Disclaimer

    Gliclize 40 should be used only under the supervision of a qualified healthcare professional. Dosage and duration of treatment should be determined by the treating physician based on the patient’s clinical condition, medical history, and therapeutic requirements.